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ABSTRACT
Gliosarcoma is a rare primary malignant tumour 
of the central nervous system. A 28-year-old 
radiographer without a history of neurological 
disorder, malignancy or trauma presented with 
unprovoked seizures. He was symptom-free 
for 3 years but developed relapsed. Computed 
tomography of the brain was consistent with 
anaplastic convexity meningioma which 
was identical via intraoperative findings. 
However, the final histology revealed 
gliosarcoma of the brain. He recovered well 
postoperatively without any neurological 
deficit and had completed adjuvant chemo-
radiotherapy. He was asymptomatic during 
follow up with no tumour recurrence. 
Gliosarcoma with predominant sarcomatous 
component mimicking a meningioma has 
prolonged survival as compared to a case with 
predominant glioblastoma component. Hence, 
the discordance between clinical, radiological, 
intraoperative and histopathological findings 
is a challenge in establishing a diagnosis 
of gliosarcoma. 
INTRODUCTION
Gliosarcoma is a rare primary malignant tumour 
of the central nervous system with reported 
cases of 0.59 – 0.76% of all adult brain tumours. 
It is a variant of glioblastoma describing 
a biphasic tissue component displaying 
glial and mesenchymal differentiation. 
Gliosarcoma constitutes approximately 2% to 
8% of all glioblastoma1. The age distribution 
is equivalent to glioblastoma which occurs 
between the ages of 40 to 60. Rare cases may 
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occur in children, even in the very young. Males 
are more frequently affected. Gliosarcoma is 
usually located in the cerebral hemispheres, 
involving the temporal, frontal, parietal 
and occipital lobes, in decreasing order of 
frequency. It has abrupt symptoms reflecting 
tumour location and raised intracranial 
pressure2. 
The histopathological evaluation shows 
a GFAP-negative malignant mesenchymal 
component, which is important to distinguish 
gliosarcoma from glioblastoma with a florid 
fibroblastic proliferation (desmoplasia) in the 
presence of meningeal invasion. Reticulin stain 
reveals a biphasic tissue pattern consisting 
of reticulin-rich sarcomatous and reticulin-
free gliomatous elements2. Gliosarcoma 
has a poor prognosis with an average of 4 
months of survival in untreated patients. It 
may show prolonged survival after surgical 
excision combined with radiotherapy and 
chemotherapy3. Gliosarcoma that mimics 
meningioma histologically has been reported 
to have a more favourable prognosis4. We 
present here a case of gliosarcoma in a young 
adult with the clinical impression of anaplastic 
convexity meningioma that has a prolonged 
survival after treatment. 
CASE PRESENTATION
A 28-year-old radiographer presented with 
two episodes of unprovoked seizure. He had 
no past medical history especially neurological 
disorder or family history of malignancy. He 
denied a history of trauma, fall, motor vehicle 
accident and fever. He had plain computed 
tomography (CT) brain done which showed 
normal findings. He was started on Tablet 
Sodium Valproate 400 mg twice daily. There 
was no further test done to investigate the 
seizure. He had defaulted his follow-up and 
medication subsequently. 
He remained symptom-free for 3 
years until the unprovoked seizure recurred. 
This episode of seizure was followed by an 
attack of severe headache 2 weeks after. He 
sought medical attention after 2 days of the 
headache. He experienced the headache on 
the parietal and periorbital region of both 
sides. It was throbbing in nature and worsened 
in the morning. There was nausea but no 
vomiting. There was no blurring of vision or 
other symptoms of neurological impairment. 
Upon presentation, he was conscious with no 
neurological deficit on peripheral and cranial 
nerves examination. 
Contrast-enhanced CT brain revealed 
an intracranial right parietal mass with 
surrounding mass effect. Magnetic resonance 
imaging (MRI) of the brain showed a 
heterogeneous solid lesion on right parieto-
occipital region measuring 4.5×2.9×5.4 cm 
which was gadolinium-enhanced. There 
was multi-age haemorrhage within the 
solid lesion with an adjacent rim enhancing, 
well-defined homogeneous cystic lesion 
measuring 3.3×2.3×3.2 cm, surrounded by the 
oedematous white matter. There was a midline 
shift to the right and mass effect with no 
dilation of ventricles. Right parieto-occipital 
craniotomy and excision of the tumour was 
performed by the neurosurgical team. The 
clinical impression was anaplastic convexity 
meningioma. There was no residual tumour 
seen on post-operative imaging.  
Histopathological report of the 
tumour revealed an irregular piece of tissue 
measuring 50×45×20 mm with multiple 
areas of haemorrhage on gross examination. 
Microscopic examination showed a biphasic 
cellular tumour composed of glial and 
sarcomatous components (Figure 1A). The glial 
component exhibited pleomorphic astrocytic 
cells with palisading necrosis (Figure 2A) and 
endothelial hyperplasia or microvascular 
proliferation with glomeruloid in appearance 
(Figure 3A). The tumour cells were moderately 
pleomorphic, having round to oval nuclei, 
fine chromatin, some showed visible nucleoli 
and cytoplasm of indistinct cell border with 
numerous mitoses (Figure 4A). 
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shift to the right and mass effect with no dilation of ventricles. Right parieto-occipital craniotomy and 
excision of the tumour was performed by the neurosurgical team. The clinical impression was anaplastic 
convexity meningioma. There was no residual tumour seen on post-operative imaging.   
 
Histopathological report of the tumour revealed an irregular piece of tissue measuring 50×45×20 mm 
with multiple areas of haemorrhage on gross examination. Microscopic examination showed a biphasic 
cellular tumour composed of glial and sarcomatous components (Figure 1A). The glial component 
exhibited pleomorphic astrocytic cells with palisading necrosis (Figure 2A) and endothelial hyperplasia 
or microvascular proliferation with glomeruloid in appearance (Figure 3A). The tumour cells were 
moderately pleomorphic, having round to oval nuclei, fine chromatin, some showed visible nucleoli 






















Figure 1 Photomicrograph: (1A) Biphasic cellular tumour composed of glial and sarcomatous 
components (H&E, ×20), (1B) Glial components with pleomorphic astrocytic cells and palisading 
necrosis (H&E, ×20), (1C) Endothelial hyperplasia or microvascular proliferation with glomeruloid in 







Figure 1 Photomicrograph: (1A) Biphasic cellular tumour composed of glial and sarcomatous 
components (H&E, ×20), (1B) Glial components with pleomorphic astrocytic cells and palisading 
necrosis (H&E, ×20), (1C) Endothelial hyperplasia or microvascular proliferation with glomeruloid in 
app arance (arrow) (H&E, ×10), (1D) Pleomorphic spindle cells with numerous mitosis (arr w) (H&E, 
×40)
The tumour cells expressed Glial 
Fibrillary Acid Protein (GFAP) (Figure 2A), S-100 
(Figure 2B) and Vimentin (Figure 2C) but did 
not express Epithelial Membrane Antigen 
(EMA), Progesterone Receptor (PR), E-cadherin, 
Pan Cytokeratin AE1/AE3, Cytokeratin 7, 
Cytokeratin 5/6 and Smooth Muscle Actin 
(SMA). Thus, a diagnosis of meningioma was 
excluded. Proliferative index Ki-67 was high 
(Figure 2D). Hence, the findings were in favour 
of Gliosarcoma, WHO grade IV.
2A2C
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The tumour cells expressed Glial Fibrillary Acid Protein (GFAP) (Figure 2A), S-100 (Figure 2B) and 
Vimentin (Figure 2C) but did not express Epithelial Membrane Antigen (EMA), Progesterone Receptor 
(PR), E-cadherin, Pan Cytokeratin AE1/AE3, Cytokeratin 7, Cytokeratin 5/6 and Smooth Muscle Actin 
(SMA). Thus, a diagnosis of meningioma was excluded. Proliferative index Ki-67 was high (Figure 





















Figure 2 Photomicrograph: Tumour cells are positive for: (2A) GFAP, (2B), S-100, (2C) Vimentin 
with high Ki-67 proliferation rate, (2D) immunohistochemistry (×20)  
 
The patient recovered well postoperatively and was asymptomatic. He was discharged 4 days after the 
operation. There was no neurological deficit. Adjuvant three-dimensional conformal radiotherapy (RT) 
and chemotherapy were given to the patient. He completed 6 cycles of adjuvant chemotherapy and was 
asymptomatic during follow up with no tumour recurrence. He was planned for surveillance with 








i r h:  r   for: (2A) GFAP, (2B), S-100, (2C) Vimentin with
high Ki-67 proliferation rate, (2D) immunohistochemistry (×20) 
The patient recovered well 
postoperatively and was asymptomatic. He was 
discharged 4 days after the operation. There 
was no neurological deficit. Adjuvant three-
dimensional conformal radiotherapy (RT) and 
chemotherapy were given to the patient. He 
completed 6 cycles of adjuvant chemotherapy 
and was asymptomatic during follow up with 
no tumour recurrence. He was planned for 
surveillance with repeated MRI brain in every 
six months, or earlier if symptomatic.
DISCUSSION
Gliosarcoma was first described by Stroebe in 
1895. It is an uncommon brain tumour and the 
reported incidence is 1 – 8% of all malignant 
gliomas and thus represents an exceptionally 
rare malignancy1. Recent genetic studies 
suggest a monoclonal origin of gliosarcoma 
and evolution of the sarcomatous component 
due to an acquisition of a mesenchym l
phenotype in a highly malignant astrocytic 
tumour. Genetic aberrations, clinical features, 
and prognosis are similar to those of 
glioblastoma multiforme5.  
Gliosarcoma commonly occurs among 
elderly with rapid clinical manifestation. 
However, in this case, the patient is only 28 years 
old with a 3-year symptom-free interval after 
the first episode. It is generally supratentorial 
with the commonest site at the temporal 
region1. As described, the tumour location 
correlates well with this case. In the literature 
review, neuroimaging for gliosarcoma may 
have 2 types; a predominant sarcomatous 
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component that may mimic a meningioma 
or with a predominant glial component that 
gives similar radiological features to those of 
glioblastoma2. In this case, radiological and 
intraoperative findings were suggestive of an 
anaplastic convexity meningioma. 
It was a challenging case because of 
the discordance between clinical radiological, 
intraoperative and microscopic findings in 
which clinically and radiologically are in favour 
of benign tumour. A preliminary diagnosis of 
anaplastic convexity meningioma made the 
histopathological evaluation more challenging, 
plus a predominant sarcomatous component 
was seen microscopically. Extensive 
immunohistochemical studies had been done 
to establish the diagnosis of gliosarcoma. 
Also, the patient’s age and atypical clinical 
presentation made the differential diagnosis 
in favour of a benign tumour. However, since 
our patient was a radiographer who had been 
frequently exposed to radiation, we couldn’t 
rule out the possibility of malignancy. 
In general, patients with gliosarcoma 
that mimics meningioma clinically have longer 
survival. Those who have tumour-resembling 
meningioma grossly usually have 16 months 
of median survival as compared to only 9.6 
months in those resembling glioblastoma4. 
In other case series, Salvati et al.5 highlighted 
the presence of 2 histological subtypes of 
gliosarcoma that are gliosarcoma with a 
prevalence of sarcomatous component and 
gliosarcoma with a prevalence of gliomatous 
component. The former has similar surgical 
and radiological features with meningioma 
with longer median survival time while the 
latter is similar to glioblastomas surgically and 
radiologically5. In term of tumour recurrent, 
patient with predominant sarcomatous 
component recurred later (mean of 59.7 weeks) 
as compared to gliomatous predominance 
with a mean recurrent period of 47 weeks)5. It 
is correlated well with this case as the patient 
still free from tumour recurrent. 
Despite the longer survival time 
for gliosarcoma mimicking meningioma, 
primary gliosarcoma, in general, is clinically 
challenging due to poor prognosis, rarity 
and limited experience in managing this rare 
variant6. Besides, managing gliosarcoma can 
be even more challenging if it is extracranial. 
Gliosarcoma can be extracranial and multifocal 
with a reported case of the multifocal spinal 
cord and meningeal involvement of this type 
of tumour7. Therefore, this case is to highlight 
the presence of this rare variant of a brain 
tumour and its challenges.
CONCLUSION
In conclusion, individuals with high-risk 
radiation exposure particularly radiographer 
as in our case require special attention when 
it comes to the diagnosis of malignancy. 
Despite indolent clinical presentations 
mimicking benign nature of the disease, 
thorough evaluation has to be made to avoid 
misdiagnosis and subsequently leading to 
mismanagement of the patient. 
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